论文部分内容阅读
目的 评价鸦胆子油“夹馅法”栓塞治疗与瘤内注射免疫因子联合治疗中晚期原发性肝癌和晚期肺癌的临床疗效。方法 将 43例中晚期不能切除的肝癌病人及 6 4例晚期肺癌病人分为两组。A组 5 5例 ,在给予瘤内局部注射免疫因子治疗同时 ,分别交替进行经肝动脉鸦胆子油 -碘油 -抗癌剂“夹馅法”栓塞化疗 (TAE)或经支气管动脉灌注化疗 (BAI)。B组 5 2例单纯给予TAE和BAI治疗。结果 两组完全缓解率 ,生存率均有显著差异。结论 动脉灌注化疗联合免疫因子瘤内注射治疗 ,使Ⅱ期手术成为可能。
Objective To evaluate the clinical efficacy of Brucea javanica oil-filling embolization and intratumoral injection of immune factors in the treatment of advanced primary liver cancer and advanced lung cancer. Methods Forty-three patients with advanced and unresectable liver cancer and 64 patients with advanced lung cancer were divided into two groups. In group A, 55 patients were treated with intratumoral local injection of immune factors, and transcatheter arterial chemoembolization (TAE) or transbronchial arterial infusion chemotherapy was performed alternately. BAI). In Group B, 52 patients were treated with TAE and BAI alone. Results There was a significant difference in survival rates between the two groups. Conclusion Arterial infusion chemotherapy combined with intratumoral injection of immune factors makes it possible to perform phase II surgery.